Ibritumomab Intravenous and Levalbuterol Inhalation, oral/nebulization
Determining the interaction of Ibritumomab Intravenous and Levalbuterol Inhalation, oral/nebulization and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: ibritumomab
Brand name: Y-90 Zevalin, In-111 Zevalin
Synonyms: Ibritumomab, Ibritumomab Tiuxetan
Generic Name: levalbuterol
Brand name: Xopenex, Xopenex Concentrate, Xopenex HFA
Synonyms: Levalbuterol inhalation, Levalbuterol
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Ibritumomab Intravenous-Levamisole
- Ibritumomab Intravenous-Levaquin
- Ibritumomab Intravenous-Levaquin (Levofloxacin Injection)
- Ibritumomab Intravenous-Levaquin (Levofloxacin Oral Solution)
- Ibritumomab Intravenous-Levaquin (Levofloxacin Tablets)
- Ibritumomab Intravenous-Levaquin injection
- Levalbuterol Inhalation, oral/nebulization-Ibritumomab Tiuxetan
- Levalbuterol Inhalation, oral/nebulization-Ibrutinib
- Levalbuterol Inhalation, oral/nebulization-Ibrutinib Capsules
- Levalbuterol Inhalation, oral/nebulization-Ibrutinib Tablets
- Levalbuterol Inhalation, oral/nebulization-Ibu
- Levalbuterol Inhalation, oral/nebulization-IBU Tablets